Transforming Drug and Chemical Discovery into a Design Process
Qulab, a pharma-chemical company, today announced Quleap, the first integrated artificial intelligence (AI)-based platform for small molecule drug design.
We are excited to join Open Force Field consortium, a joint experimental-theoretical effort to develop next generation of high-quality biomolecular force fields.
Today we’re announcing partnerships with some of the world’s leading startup talent in quantum software and algorithm development.
Qulab, a computational molecular design company, today announced it has joined Rigetti’s new Quantum Cloud Services developer partner program.